A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to assess the safety and efficacy of multiple study interventions including novel-novel combinations or novel agents in combination with standard therapy for the treatment of metastatic NSCLC.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony diagnozą rak płuca (płaskonabłonkowy lub inny typ) w stadium IV (rozprzestrzeniający się)
- •Dostępne próbki tkanki guza z przeszłości lub pobrane świeżo
- •Co najmniej jeden widoczny na obrazach zmianę guza o wielkości ≥ 10 mm
- •Oczekiwana długość życia co najmniej 12 tygodni
- •Prawidłowe funkcjonowanie organów wewnętrznych i szpiku kostnego
- •Dla podgrupy 2: wysokość białka PD-L1 w guzie co najmniej 1%
- •Minimum waga ciała 30 kg
- •Gotowość stosowania antykoncepcji zgodnie z lokalnymi wytycznymi
✗ Disqualifies
- •Guz z mutacją genu EGFR lub fuzją receptora ALK (gdy istnieje już leczenie ukierunkowane)
- •Obecność małokomórkowego raka płuca lub neuroendokrynnego typu
- •Niekontrolowane choroby układowe (ciężkie nadciśnienie, zaburzenia krwawienia, aktywne infekcje)
- •Choroba śródmiąższowa płuc lub zapalenie płuc (w jakimkolwiek stopniu)
- •Historia przeszczepu szpiku kostnego, tkanki lub narządu
- •Aktywna choroba autoimmunologiczna wymagająca leczenia w ostatnich 5 latach
- •Historia poważnych zaburzeń rytmu serca, kardiomiopatii lub niewydolności serca
- •Wcześniejszy nowotwór złośliwy (za wyjątkiem określonych przypadków)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 21, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (103)
Research Site
Phoenix, United States
Research Site
Santa Rosa, United States
Research Site
Jacksonville, United States
Research Site
Baltimore, United States
Research Site
Detroit, United States
Research Site
Rochester, United States
Research Site
Cleveland, United States
Research Site
Providence, United States
Research Site
Providence, United States
Research Site
Tyler, United States
Research Site
Anderlecht, Belgium
Research Site
Hasselt, Belgium
Research Site
Leuven, Belgium
Research Site
Barretos, Brazil
Research Site
Fortaleza, Brazil
Research Site
Natal, Brazil
Research Site
Pelotas, Brazil
Research Site
Porto Alegre, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil
Research Site
Chengdu, China
Research Site
Chongqing, China
Research Site
Deyang, China
Research Site
Fuzhou, China
Research Site
Guangzhou, China
Research Site
Jinan, China
Research Site
Shanghai, China
Research Site
Shanghai, China
Research Site
Shenyang, China
Research Site
Shenzhen, China
Research Site
Wuhan, China
Research Site
Wuhan, China
Research Site
Bordeaux, France
Research Site
Dijon, France
Research Site
Limoges, France
Research Site
Marseille, France
Research Site
Nantes, France
Research Site
Nice, France
Research Site
Paris, France
Research Site
Batumi, Georgia
Research Site
Tbilisi, Georgia
Research Site
Tbilisi, Georgia
Research Site
Tbilisi, Georgia
Research Site
Tbilisi, Georgia
Research Site
München, Germany
Research Site
Münster, Germany
Research Site
Oldenburg, Germany
Research Site
Regensburg, Germany
Research Site
Würzburg, Germany
Research Site
Milan, Italy
Research Site
Milan, Italy
Research Site
Orbassano, Italy
Research Site
Pavia, Italy
Research Site
Roma, Italy
Research Site
Bunkyō City, Japan
Research Site
Bunkyō City, Japan
Research Site
Kashiwa, Japan
Research Site
Kurume-shi, Japan
Research Site
Kyoto, Japan
Research Site
Niigata, Japan
Research Site
Shinjuku-ku, Japan
Research Site
Toyoake-shi, Japan
Research Site
Kuala Lumpur, Malaysia
Research Site
Kuala Selangor, Malaysia
Research Site
Kuching, Malaysia
Research Site
Singapore, Malaysia
Research Site
Chisinau, Moldova
Research Site
Amsterdam, Netherlands
Research Site
Groningen, Netherlands
Research Site
Leiden, Netherlands
Research Site
Lima, Peru
Research Site
Koszalin, Poland
Research Site
Lodz, Poland
Research Site
Olsztyn, Poland
Research Site
Belgrade, Serbia
Research Site
Kragujevac, Serbia
Research Site
Niš, Serbia
Research Site
Seongbuk-Gu, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Barcelona, Spain
Research Site
Barcelona, Spain
Research Site
L'Hospitalet de Llobregat, Spain
Research Site
Madrid, Spain
Research Site
Madrid, Spain
Research Site
Pamplona, Spain
Research Site
Pozuelo de Alarcón, Spain
Research Site
Valencia, Spain
Research Site
Valencia, Spain
Research Site
Taichung, Taiwan
Research Site
Taipei, Taiwan
Research Site
Taipei, Taiwan
Research Site
Bangkok, Thailand
Research Site
Chanthaburi, Thailand
Research Site
Hat Yai, Thailand
Research Site
Khon Kaen, Thailand
Research Site
Rachathewi, Thailand
Research Site
Ankara, Turkey (Türkiye)
Research Site
Ankara, Turkey (Türkiye)
Research Site
Fatih, Turkey (Türkiye)
Research Site
Istanbul, Turkey (Türkiye)
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/22/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.